Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024Drug Development Research

YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

JYJian YangYCYa‐Wen ChenYHYang He

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2024) studied this question.

synapsesocial.com/papers/68e70ef4b6db6435876883e1https://doi.org/10.1002/ddr.22179
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1YTHDF1 Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer Cells via Upregulating TCF7 mRNA Translation2024 · 4 citations
  2. 2YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p532024 · 3 citations
  3. 3Knockdown of YTHDF2 initiates ERS-induced apoptosis and cancer stemness suppression by sustaining GLI2 stability in cervical cancer2024 · 5 citations
  4. 4YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer2025
  5. 5<scp>YTHDF3</scp> Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the <scp>mTOR</scp> – <scp>HIF1α</scp> – <scp>LHDA</scp> Axis2026